Cambridge scientists have identified a key protein that could act as a predictor for preeclampsia and fetal growth restriction, two of the major causes of stillbirth and illness among mothers and newborns. The discovery helps explain why placental cells fail to properly "invade" the uterus in these related conditions and could lead to tests that help identify those at greatest risk and new treatments. The findings are published in Nature Medicine.
Discovery of Key Protein May Lead to New Tests and Treatments for Preeclampsia
Cambridge scientists have discovered a key protein that may predict preeclampsia and fetal growth restriction, which are significant causes of stillbirth and illness in mothers and newborns. This research could lead to new tests and treatments for at-risk pregnancies. Although the article does not directly relate to Iran, advancements in maternal health could have implications for healthcare practices in the country.
👥 Key Players
📰 What Happened
Cambridge scientists have discovered a key protein that could help predict preeclampsia and fetal growth restriction, potentially leading to new tests and treatments for at-risk pregnancies.
- The discovery could help reduce stillbirth and illness among mothers and newborns.
- The findings were published in the reputable journal Nature Medicine.
💡 Why It Matters
📚 Background
Preeclampsia is a serious pregnancy complication characterized by high blood pressure and can lead to severe health issues for both mother and child.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%